Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
- PMID: 33454844
- PMCID: PMC7897189
- DOI: 10.1007/s10555-021-09955-5
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
Erratum in
-
Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?Cancer Metastasis Rev. 2024 Jun;43(2):845. doi: 10.1007/s10555-021-09966-2. Cancer Metastasis Rev. 2024. PMID: 33860435 No abstract available.
Similar articles
-
Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.Stem Cells. 2016 Mar;34(3):551-64. doi: 10.1002/stem.2279. Epub 2016 Feb 2. Stem Cells. 2016. PMID: 26800320
-
The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.Tumour Biol. 2017 Mar;39(3):1010428317694544. doi: 10.1177/1010428317694544. Tumour Biol. 2017. PMID: 28347252 Review.
-
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.Mediators Inflamm. 2017;2017:9173090. doi: 10.1155/2017/9173090. Epub 2017 Dec 21. Mediators Inflamm. 2017. PMID: 29430083 Free PMC article. Review.
-
ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.BMC Cancer. 2018 Dec 19;18(1):1273. doi: 10.1186/s12885-018-5166-z. BMC Cancer. 2018. PMID: 30567518 Free PMC article.
-
Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.Biochem Soc Trans. 2012 Feb;40(1):31-6. doi: 10.1042/BST20110608. Biochem Soc Trans. 2012. PMID: 22260662 Free PMC article. Review.
Cited by
-
Dysregulated ATX-LPA and YAP/TAZ signaling in dystrophic Sgcd-/- mice with early fibrosis and inflammation.Skelet Muscle. 2025 Mar 6;15(1):6. doi: 10.1186/s13395-025-00375-5. Skelet Muscle. 2025. PMID: 40050938 Free PMC article.
-
Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma.Sci Rep. 2024 Nov 3;14(1):26540. doi: 10.1038/s41598-024-77285-x. Sci Rep. 2024. PMID: 39489756 Free PMC article.
-
Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer.Mol Pharm. 2023 Nov 6;20(11):5500-5514. doi: 10.1021/acs.molpharmaceut.3c00348. Epub 2023 Oct 16. Mol Pharm. 2023. PMID: 37844135 Free PMC article.
-
Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.Molecules. 2022 Aug 26;27(17):5487. doi: 10.3390/molecules27175487. Molecules. 2022. PMID: 36080255 Free PMC article. Review.
-
LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10.Acta Pharmacol Sin. 2025 Jan;46(1):222-230. doi: 10.1038/s41401-024-01373-x. Epub 2024 Aug 26. Acta Pharmacol Sin. 2025. PMID: 39187677 Free PMC article.
References
-
- Seo EJ, Kwon YW, Jang IH, Kim DK, Lee SI, Choi EJ, Kim KH, Suh DS, Lee JH, Choi KU, Lee JW, Mok HJ, Kim KP, Matsumoto H, Aoki J, Kim JH. Autotaxin regulates maintenance of ovarian cancer stem cells through lysophosphatidic acid-mediated autocrine mechanism. Stem Cells. 2016;34(3):551–564. doi: 10.1002/stem.2279. - DOI - PubMed
-
- Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, Miller D, Sahay D, Ribeiro J, Clézardin P, Tigyi GJ, Peyruchaud O. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood. 2014;124(20):3141–3150. doi: 10.1182/blood-2014-04-568683. - DOI - PMC - PubMed
-
- Auciello FR, Bulusu V, Oon C, Tait-Mulder J, Berry M, Bhattacharyya S, Tumanov S, Allen-Petersen BL, Link J, Kendsersky ND, Vringer E, Schug M, Novo D, Hwang RF, Evans RM, Nixon C, Dorrell C, Morton JP, Norman JC, Sears RC, Kamphorst JJ, Sherman MH. A stromal lysolipid-autotaxin signaling axis promotes pancreatic tumor progression. Cancer Discovery. 2019;9(5):617–627. doi: 10.1158/2159-8290.Cd-18-1212. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical